Clinical Trials
27 trialsA Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)
Eureka Therapeutics Inc.
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Pfizer
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors
Pfizer
CheckMate 76U
Bristol-Myers Squibb
SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
ET-109
Eureka Therapeutics Inc.
Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms
National Institutes of Health Clinical Center (CC)
Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
Washington University School of Medicine
High Dose Rate Brachyablation of Primary Liver Lesions
University of Texas Southwestern Medical Center
Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads
National Institutes of Health Clinical Center (CC)
Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma
Aeon Therapeutics (Shanghai) Co., Ltd.
An Open Study Assessing the Safety and Tolerability of U3-1784
Daiichi Sankyo
Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization
Washington University School of Medicine
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Masonic Cancer Center, University of Minnesota
MT2004-30: Tomotherapy for Solid Tumors
Masonic Cancer Center, University of Minnesota
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
Masonic Cancer Center, University of Minnesota
A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy
Merck KGaA, Darmstadt, Germany
Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer
Celgene
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
University of Pittsburgh
Definity®
University of Louisville
Gene Therapy in Treating Patients With Cancer of The Liver
National Cancer Institute (NCI)
Proton Therapy and Bevacizumab for Primary Liver Tumors
M.D. Anderson Cancer Center
Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis
UNC Lineberger Comprehensive Cancer Center
Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by Surgery
Case Comprehensive Cancer Center
Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases
Stanford University
Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma
James A. Haley Veterans Administration Hospital